What is the recommended titration schedule for increasing gabapentin enacarbil dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Gabapentin Enacarbil Titration Schedule

For gabapentin enacarbil, initiate at 600 mg once daily at approximately 5 p.m. with food, then increase by 600 mg increments every 3 days up to the target dose of 1200 mg once daily. 1

Standard Titration Protocol

The FDA-approved titration schedule for gabapentin enacarbil is straightforward:

  • Starting dose: 600 mg once daily
  • Titration interval: Every 3 days
  • Increment size: 600 mg
  • Target dose: 1200 mg once daily (for restless legs syndrome)
  • Timing: Take at approximately 5 p.m. with food 1

Important Distinctions from Regular Gabapentin

Do not confuse gabapentin enacarbil with immediate-release gabapentin - they have completely different titration schedules. Regular gabapentin requires much slower titration starting at 100-300 mg with increases every 1-7 days 2, whereas gabapentin enacarbil is a prodrug with predictable linear pharmacokinetics that allows for faster, simpler dose escalation 3.

Dose Selection Considerations

While the FDA approved only the 600 mg dose for restless legs syndrome based on safety concerns, clinical trial evidence shows:

  • 600 mg once daily: Effective for subjective RLS symptoms with lower rates of somnolence and dizziness 3, 4
  • 1200 mg once daily: Most validated dose for both RLS symptoms and severe sleep disturbance, though with higher adverse event rates 4
  • Higher doses (1800-2400 mg): Show no additional benefit over 1200 mg and significantly increase side effects 3

The therapeutic window is narrow - model-derived data shows therapeutic indices ranging from only 1.08 to 1.20, meaning the effective dose is very close to the dose causing side effects 5.

Renal Adjustment

Gabapentin enacarbil requires dose reduction in renal impairment. While the FDA label for regular gabapentin provides detailed creatinine clearance-based adjustments 1, apply similar principles for gabapentin enacarbil by reducing doses proportionally to renal function.

Common Pitfalls to Avoid

  • Don't titrate too slowly: The 3-day interval is evidence-based; slower titration is unnecessary and delays therapeutic benefit
  • Don't exceed 1200 mg daily: Higher doses provide no additional efficacy and substantially increase dizziness and somnolence 3
  • Don't skip the food requirement: Gabapentin enacarbil absorption is optimized with food intake
  • Don't use morning dosing: The 5 p.m. timing is specifically designed to provide peak levels during typical RLS symptom onset

Discontinuation

When stopping gabapentin enacarbil, taper gradually over a minimum of 1 week to avoid withdrawal symptoms 1. A longer taper may be needed at prescriber discretion.

Related Questions

What is the difference between gabapentin enacarbil (Horizant) and gabapentin (Neurontin)?
What is the recommended treatment for an adult patient with moderate-to-severe Restless Legs Syndrome (RLS) or primary periodic limb movement disorder, comparing Horizant (gabapentin enacarbil) to gabapentin, considering potential renal impairment?
Can I take regular gabapentin (Gabapentin) during the day if I'm already taking Horizant (Gabapentin Enacarbil)?
What is the appropriate gabapentin dosing regimen for an adult with restless‑legs syndrome, including initial dose, titration schedule, maximum dose, and adjustments for older adults or impaired renal function?
What is the recommended dosing for Horizant (Gabapentin Enacarbil) in patients with moderate-to-severe Restless Legs Syndrome (RLS) or Postherpetic Neuralgia (PHN)?
How can I raise a patient's hemoglobin without adding iron?
What is the initial target arterial oxygen saturation for optimal neurological resuscitation after return of spontaneous circulation following cardiopulmonary resuscitation?
What is causing my medication‑induced partially rigid erection (partial priapism) after taking tadalafil (5 mg daily for two weeks then a single 10 mg dose) and sildenafil (two 30 mg doses taken close together), and how should it be managed?
Why am I still able to achieve a partial or semi‑erection despite penile fibrosis, venous leakage, and recent use of tadalafil (Cialis) and sildenafil (Viagra)?
Can a patient with an AST (aspartate aminotransferase) level of 125 U/L safely take metformin?
Why am I still experiencing partial erections a month after stopping tadalafil (Cialis) and sildenafil (Viagra)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.